Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Geschwindt

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 30, 2007
Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivinDaniel M Kenney, Ryan D Geschwindt, Marcia R Kary, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
Clinical Chemistry|February 10, 2007
MESOMARK: a potential test for malignant pleural mesotheliomaHeather L Beyer, Ryan D Geschwindt, Curtis L Glover, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 30, 2007
Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivinDaniel M Kenney, Ryan D Geschwindt, Marcia R Kary, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
Clinical Chemistry|February 10, 2007
MESOMARK: a potential test for malignant pleural mesotheliomaHeather L Beyer, Ryan D Geschwindt, Curtis L Glover, et al.
Pageof 1